IWAKI CO.,LTD. FY2027 Q1 Earnings Report

Financial Highlights

• Net Sales: ¥12.95B
• Operating Income: ¥1.65B
• Net Income: ¥1.45B
• EPS: ¥64.67

Income Statement

Balance Sheet

Profitability Ratios

Year-over-Year Comparison

Share Information

Full Year Forecast

---

AI Financial Analysis

Executive Summary

FY2027 Q1 was a clear beat with double-digit top-line growth and stronger operating leverage. Revenue rose 15.1% YoY to 12.945bn JPY, while operating income climbed 28.2% to 1.648bn JPY and net income grew 41.5% to 1.434bn JPY. Operating margin expanded by roughly 131 bps YoY to 12.7%, supported by disciplined SG&A control against higher volumes. Gross margin printed at 39.8%, a modest ~30 bps compression YoY, but this was more than offset by improved operating efficiency. Ordinary income increased 26.4% to 1.966bn JPY, with ordinary margin up ~136 bps to 15.2%, aided by 0.22bn JPY in equity-method income and a 0.50bn JPY FX gain within non-operating income. Net margin improved ~206 bps YoY to 11.1%, with EPS of 64.67 JPY. Interest coverage is very strong at 72.2x, reflecting low financial risk. The balance sheet is robust: current ratio 372%, quick ratio 321%, and debt/capital 5.7%, with cash covering short-term loans by over 12x. Capital efficiency remains subdued with ROE at 3.4% for the period on low asset turnover of 0.226, consistent with a working-capital-heavy model. Working capital intensity is the main constraint, as receivable days of 264 and inventory days of 590 push the cash conversion cycle to an elevated 750 days. Ordinary profit benefited from non-operating tailwinds (FX gains and equity-method income), though these represented only a small share of revenue (~2.7%). Extraordinary items were negligible. Versus full-year guidance, Q1 progress is on or slightly ahead of a standard run-rate: sales 25.4%, operating income 25.6%, ordinary income 28.1%, and net income 27.8%. The quarter’s performance implies manageable upside risk to guidance if demand and pricing hold and working capital normalizes. Overall, the print signals healthy demand in chemical pumps, with strong execution and low financial risk, but underscores the need to address long-cycle working capital to unlock higher ROE.

Profitability Analysis

ROE decomposes into Net Profit Margin (11.1%) × Asset Turnover (0.226) × Financial Leverage (1.36x) = 3.4%. The largest positive change came from margins: operating margin expanded ~131 bps YoY to 12.7% and net margin by 206 bps, while gross margin was essentially flat to slightly lower (-30 bps). The business driver appears to be operating leverage from revenue growth outpacing SG&A (+28.2% OI on +15.1% revenue) and modest non-operating support (equity-method income and FX gains). This margin improvement is partially sustainable if demand and pricing remain intact and SG&A discipline continues; the non-operating tailwinds are less predictable. Asset turnover remains low at 0.226, reflecting long receivable and inventory cycles that tie up capital; without working capital reform, this will continue to cap ROE. Financial leverage is conservative at 1.36x, limiting ROE amplification but keeping risk low. A noteworthy trend is SG&A growth trailing gross profit growth, indicating positive operating leverage.

Growth Assessment

Revenue grew 15.1% YoY to 12.945bn JPY, with operating income up 28.2% and ordinary income up 26.4%, signaling healthy demand and pricing. Net income rose 41.5%, outpacing revenue on margin expansion and modest non-operating support. Operating margin reached 12.7% (good per benchmark), and net margin reached 11.1% (excellent). Progress versus full-year guidance is slightly ahead of the typical 25% Q1 run-rate: sales 25.4%, OP 25.6%, OI 28.1%, NI 27.8%, suggesting cushion if Q2–Q4 track seasonally. Equity-method income of 0.22bn JPY and FX gains of 0.50bn JPY lifted ordinary profit but are not the primary growth driver. The outlook hinges on sustaining order momentum in chemical pumps and tightening working capital to convert earnings into cash. With strong liquidity and low leverage, the company is well-positioned to fund growth initiatives.

Financial Health

Liquidity is very strong: current ratio 371.8% and quick ratio 321.1%, with 9.8bn JPY in cash and deposits. There are no threshold warnings (Current Ratio well above 1.0 and D/E well below 2.0). Capital structure is conservative: debt/capital 5.7% and D/E 0.36x, with interest-bearing debt of 25.6bn JPY against equity of 421.9bn JPY (units: 100M JPY). Short-term loans are 0.812bn JPY versus cash of 9.799bn JPY (cash/short-term debt 12.1x), implying no near-term liquidity strain. Maturity profile is comfortable: current liabilities of 10.43bn JPY are well covered by current assets of 38.80bn JPY. The shift of the current portion of long-term loans to 0.571bn JPY (up ~78% YoY) is readily manageable given cash on hand. No off-balance sheet obligations of concern are noted.

Notable B/S Changes

Provision for bonuses: -8.03bn JPY (-58%) YoY - lower accrual reduces near-term current liabilities and may reflect prior period payout normalization. Provision for directors' bonuses: -0.85bn JPY (-62%) YoY - further easing of short-term obligations. Other current liabilities: +1.95bn JPY (+100%) YoY - higher operational liabilities increase, warrants monitoring for timing effects. Deferred tax assets: +2.85bn JPY (+84%) YoY - rise suggests timing differences; monitor for future reversals. Current portion of long-term loans: +0.25bn JPY (+78%) YoY - modest front-loading of debt maturities, readily covered by cash.

Cash Flow Quality

Working capital intensity is the principal quality headwind: DSO of 264 days and DIO of 590 days drive a long cash conversion cycle of 750 days, heightening cash collection and obsolescence risks. Receivables (9.36bn JPY plus electronically recorded claims of 5.89bn JPY) are sizable relative to quarterly sales, underscoring collection discipline as a key focus. Inventories total 5.29bn JPY with a high finished goods component, suggesting scope to optimize production planning and sales throughput. Provisions for bonuses decreased materially (to 0.58bn JPY), which may reduce near-term cash requirements compared to the prior period accrual. With strong cash reserves and minimal net debt, the company has ample capacity to fund operations and dividends while working through the long cycle. Sustained improvement in receivables collection and inventory turns would materially enhance earnings-to-cash conversion.

Dividend Sustainability

Full-year DPS guidance is 92 JPY versus EPS guidance of 231.94 JPY, implying a payout ratio of approximately 39.7%, well within sustainable levels. Balance sheet strength (cash 9.8bn JPY, low leverage) provides a solid buffer for dividends. Interest expense is minimal (0.023bn JPY) relative to profits, limiting cash leakage. The current profitability trajectory and liquidity profile indicate good coverage of dividends alongside routine investment needs under the base-case outlook. Execution on working capital normalization would further reinforce sustainability.

Risk Assessment

Business risks include Demand cyclicality in industrial and chemical end-markets affecting pump orders and utilization, Prolonged receivable collection cycle (DSO 264 days) increasing credit concentration and collection risk, High inventory days (DIO 590) raising obsolescence and carrying-cost risk, FX volatility impacting non-operating income and translation effects.

Financial risks include Long cash conversion cycle (750 days) elevates funding needs for growth despite current liquidity strength, Potential margin sensitivity to input costs and pricing power in case of raw material or energy spikes.

Key concerns include CAPITAL_EFFICIENCY: ROIC at 3.5% is below the 5% threshold, reflecting low asset turnover; this is atypical for best-in-class industrial peers and constrains valuation resilience, HIGH_RECEIVABLE_DAYS: DSO of 264 days far exceeds the 60-day benchmark; persistent extension is a sign of weak collection terms or customer mix, elevating cash realization risk, HIGH_INVENTORY_DAYS: DIO of 590 days indicates significant inventory holding; while some buffering may be strategic, the level is well above norms and risks write-downs if demand softens, LONG_CCC: A cash conversion cycle of 750 days materially increases working capital intensity; this ties up cash that could otherwise fund growth or shareholder returns, HIGH_INVENTORY_DAYS: 248 days flag reinforces the variability in inventory turn metrics across methodologies, but both indicate structurally slow turns.

Investment Implications

Key takeaways include Beat-like quarter on operating leverage: OP +28% YoY on sales +15%, OM +131 bps, Net margin at 11.1% and interest coverage >70x underscore earnings strength and low financial risk, Capital efficiency is the main drag: ROE 3.4% with asset turnover 0.226, Working capital intensity (DSO 264, DIO 590, CCC 750) is the critical improvement lever, Q1 progress modestly ahead of full-year pacing, creating cushion versus guidance.

Metrics to watch include Receivable days and aging profile; cash/AR conversion trend, Inventory turns by category (raw, WIP, finished) and obsolescence provisions, Order intake and book-to-bill for chemical pumps, Operating margin trajectory vs input cost movements, Equity-method income and FX sensitivity on ordinary profit.

Regarding relative positioning, Financial risk is lower than typical small/mid-cap industrial peers due to strong liquidity and low leverage, while capital efficiency and cash conversion are weaker than peers with tighter working capital cycles.